ea0099ep922 | Calcium and Bone | ECE2024
Anagnostis Panagiotis
, Divaris Efstathiios
, Bosdou Julia
, Tournis Symeon
, Stathopoulos Konstantinos
, Goulis Dimitrios
Objective: Menopausal hormone therapy (MHT) is efficacious in reducing the risk of vertebral, non-vertebral and hip fractures, irrespective of age, falls risk or baseline FRAX probability. However, the optimal sequential anti-osteoporotic treatment after MHT discontinuation has not yet been designated. This systematic review aimed to obtain the best evidence regarding the effect of antiresorptive or osteoanabolic treatment on bone mineral density (BMD) and/or fracture risk fol...